1. PHARMACOECONOMICS and RATIONAL DRUG USE DRAFT PROGRAM FOR 1 st ISPOR INTERNATIONAL SUMMER SCHOOL ISPOR SCP (TURKEY) ANTALYA, APRIL 17-21, 2008 PHARMACOECONOMICS and RATIONAL DRUG USE DRAFT PROGRAM FOR 1 st ISPOR INTERNATIONAL SUMMER SCHOOL ISPOR SCP (TURKEY) ANTALYA, APRIL 17-21, 2008

2.  Antalya was founded in the second century BC by a king of Pergamon (Bergama), Attalus II. He needed a harbour in the South and had to found a new city since all the other harbours were under (bought) Roman protection. The city fast outgrew the nearby Side in importance. In 67 Pompeius used it as a basis for his fight against pirates. In 130 emperor Hadrian visited the city, and for the occasion a great arch was erected. Hadrian improved the cities defences and made it the capital of a new province. In 1207 the Seljuks conquered the city, and used it as a winter residence. Murat II integrated it into the Ottoman empire in the late 14th century.

3. April 17 Thursday Check in 18.00 Welcome; 20.00 Dinner April 18 Friday 08.30 – 09.20: ISPOR SCP and Why do we need pharmacoeconomics and rational drug use? 09.20 – 10.10: General economics and health expenditures – TR 10.10 – 10.30: Coffee Break 10.30 – 11.20: Principles of pharmacoeconomics Academics 11.20 – 12.10: Pharmacoeconomics for decision makers Academics 12.10 – 13.30: Lunch 13.30 – 14.20: GSS and SGK in Turkey; next 2 years Government speaker 14.20 – 15.10: Principles of Rational drug use 15.10 – 15.30: Coffee Break 15.30 – 16.20: DRGs and payment systems 16.20 – 17.10: How to apply rational drug use in the new system: The role of generic drugs

4. April 19 Saturday 08.30 – 09.20: Reference pricing and competition?/budget impact 09.20 – 10.10: Reimbursement systems across Europe 10.10 – 10.30: Coffee Break 10.30 – 11.20: Quality of life and patient reported outcomes 11.20 – 12.10: What are we paying for? 12.10 – 13.30: Lunch 13.30 – 14.20: Budget impact of new technologies 14.20 – 15.10: Why do we need real life data with local costs? 15.10 – 15.30: Coffee Break 15.30 – 16.20: Pharmacoeconomics alongside clinical trials 16.20 – 17.10: Modeling methods and why do we need modeling?

5. April 20 Sunday 08.30 – 09.20: How does Social Security Agencies make a decision? 09.20 – 10.10: How to prepare a reimbursement file? 10.10 – 10.30: Coffee Break 10.30 – 11.20: What does it mean for the pharma sector 1? National Drug Manufacturers 11.20 – 12.10: What does it mean for the pharma sector 2? Multinational Drug Companies 12.10 – 13.30: Lunch 13.30 – 14.20: Workshop; Reimbursement File Preparation 1 14.20 – 15.10: Workshop; Reimbursement File Preparation 2 15.10 – 15.30: Coffee Break 15.30 – 16.30: Conclusion and statements of ISPOR SCP

10. The Worldwide Role of Generic Pharmaceuticals Dr Jonathan D. Quick, Director Essential Drugs and Other Medicines - EDM Health Technology and Pharmaceuticals Cluster World Health Organization June, 1999

11. Effective Drug Regulation: what can countries do? Essential Drugs and Other Medicines Department Health Technology and Pharmaceuticals Cluster World Health Organization March 1999

12. Pharmacoeconomics: What is it and where is it going? JS McCombs, Am J Hip., 11: 1125, 1998 Gained years/cost dolar

13. P = M X C B P= Performans M= Motivation C= Competence B= Barriers

14. Old system New system Patient needs Physicians’ desicion Administrators’applicatin Administrators’desicion Physicians’ application